Search results
Results from the WOW.Com Content Network
In 1996 the vaccine vial monitor was first used in a vaccine project, and by the next year it was widely accepted for use on many vaccine projects. It took until 2007 for VVMs to be widely adopted by vaccine manufacturers. by 2017, over 6.6 billion VVMs had been used.
A 2018 study into Cambodia's national immunization program found wastage rates of 0% to 60% depending on location and vaccination type. [3]A study from India which collected Universal Immunisation Programme data from two different locations (Kangra and Pune districts) between January 2016 to December 2017 found wastage rates that differed according to vaccine type, reuse type, vial size ...
Vancomycin is recommended to be administered in a dilute solution slowly, over at least 60 min (maximum rate of 10 mg/min for doses >500 mg) [21] due to the high incidence of pain and thrombophlebitis and to avoid an infusion reaction known as vancomycin flushing reaction. This phenomenon has been often clinically referred to as "red man syndrome".
A drug of last resort (DoLR), also known as a heroic dose, [1] is a pharmaceutical drug which is tried after all other drug options have failed to produce an adequate response in the patient. Drug resistance , such as antimicrobial resistance or antineoplastic resistance , may make the first-line drug ineffective, especially in case of ...
A hospital corpsman dips a bifurcated vaccination needle into an open vial of smallpox vaccine. The bifurcated needle is a narrow steel rod, approximately 5 cm (2 in) long with two prongs at one end. [1] It was designed to hold one dose of reconstituted freeze-dried smallpox vaccine between its prongs. [2]
Modified vaccinia Ankara (MVA) is an attenuated (weakened) strain of the vaccinia virus. It is being used as a vaccine (called MVA-BN, brand names: Imvanex in the EU, [3] Imvamune in Canada, [2] and Jynneos in the US [1]) against smallpox and mpox, [4] having fewer side effects than smallpox vaccines derived from other poxviruses.
A hexavalent vaccine, or 6-in-1 vaccine, is a combination vaccine with six individual vaccines conjugated into one, intended to protect people from multiple diseases. [1] [9] The term usually refers to the children's vaccine that protects against diphtheria, tetanus, pertussis, poliomyelitis, haemophilus B, and hepatitis B, [1] [9] which is used in more than 90 countries around the world ...
Vaccine storage relates to the proper vaccine storage and handling practices from their manufacture to the administration in people. [2] The general standard is the 2–8 °C cold chain for vaccine storage and transportation.